|
|
 |
SAVAYSA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
PROPYL GALLATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
PROPYLENE GLYCOL Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
RHOPRESSA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|